Here's When to See July's Spectacular Buck Moon, Along With Mars and Venus
According to Stellarium's sky map, the moon will rise from the southeastern horizon just after sunset in your local time and streak across the sky before setting on the southwestern horizon just before dawn. No matter where you are in the US, you'll be able to see it virtually all night.
Should you not be able to see the moon due to weather or other reasons, you can also soak up a great view any time from July 8-12. as the moon will be more than 95% full during those days.
Why is it called the Buck Moon or Thunder Moon?
According to The Farmer's Almanac, July's full moon actually has several names, including Buck Moon, Thunder Moon, Feather Moulting Moon, and Salmon Moon. These names typically come from Native American and colonial times and were used to describe the moon for the entire month, not just when it's full.
White-tailed deer start growing antlers in March or April as the days start to lengthen. July marks the peak of their antler growth season, hence the name Buck Moon. Thunderstorms are also common in July, which is why it's also called the Thunder Moon.
The other two names are less common, but July marks the time when some species of salmon begin migrating for the mating season, while ducks engage in their annual molting around this time of year as well.
Catch a glimpse of Mars and Venus too
The moon will be joined in the sky by Mars and Venus during its trip across the sky on July 10. Mars will be visible just after sunset in the western sky before setting. You won't have long since it's scheduled to dip below the horizon before midnight. If you choose to stay up late, Venus will crest the eastern horizon shortly after 2 a.m. local time and be visible until sunrise.
Saturn will also be visible in the eastern sky, not far from the moon, but you'll likely need binoculars or a telescope to see it with the moon's glow.
Once the moon finishes its monthly cycle, skygazers can check out the Alpha Capricornids and Southern Delta Aquariids meteor showers, both of which are scheduled to peak during the last few days of July.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
14 minutes ago
- Washington Post
Which choices contribute most to climate change? Most people miss the mark, one study found
It turns out many Americans aren't great at identifying which personal decisions contribute most to climate change. A study recently published by the National Academy of Sciences found that when asked to rank actions, such as swapping a car that uses gasoline for an electric one, carpooling or reducing food waste, participants weren't very accurate when assessing how much those actions contributed to climate change, which is caused mostly by the release of greenhouse gases that happen when fuels like gasoline, oil and coal are burned.
Yahoo
40 minutes ago
- Yahoo
Some Human Brains Are Basically Defying Time by Refusing to Grow Old
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Here's what you'll learn when you read this story: Some people's brains are so much younger than their chronological age, they could be hiding the secrets to treating dementia and other neurodegenerative diseases. Known as 'superagers,' these individuals have brains that show physical aspects which are resistant to the causes of Alzheimer's and other conditions that cause memory loss. While it is unknown whether superagers are born with larger brains or certain preconditions, future studies could reveal gene therapies and other treatments that could thwart diseases such as Alzheimer's. Ask anyone what they dread about aging, and the thought of Alzheimer's and other forms of dementia is likely an answer high on the list. The irreversible symptoms of dementia only worsen with time and can become severe enough for the person to struggle remembering the faces of those close to them and even their own identity. There is no cure for dementia (even though treatments that mitigate symptoms do exist). However, answers for prevention may lie in the brains of superagers, individuals over the age of 80 who have memories superior to others in their age group and can recall things as well as people decades younger. A Northwestern University study that spanned 25 years studied the lifestyles and brain activity of superagers both during life and in those who had donated their brains postmortem. What the researchers at the Northwestern Alzheimer's Disease Research Center found were physical differences in brain structures that delayed symptoms of brain aging that often lead to dementia. Superagers would remember at least as many words from a list read to them as neurotypical adults who were 20 to 30 years younger. Their brain age of these subjects, mostly octogenarians and novogenerians, defied the expectations of the degenerative processes that often happen to the brains of people who reach their biological age. What is considered 'normal' brain aging involves decline. The average brain usually does not stay so remarkably intact. 'During the first 25 years of this program, we established that superagers constitute not only a neuropsychological but also a neurobiological phenotype distinctive from cognitively average age peers,' they said in a study recently published in Alzheimer's & Dementia. What gives superagers these superpowers? There are several contributing factors. Somehow, their cerebral cortex resists thinning that is often a cause of neurodegenerative diseases. This outermost portion of the brain, also known as gray matter, is made of tightly packed neurons and responsible for higher-level processes that include memory, as well as learning, thought, reasoning, intelligence, language, decision-making, emotion, and personality. Superagers experience little to no cortical thinning, giving them cortical volumes similar to those of much younger brains. There are also less obvious parts of the brain that give them an advantage, such as the cingulate gyrus, which is located below the cerebral cortex and above the corpus callosum. The cingulate gyrus also processes memory, along with emotion, self-regulation and pain. Superagers have a region in the cingulate gyrus that is thicker than the same region in younger adults. Their brains also show fewer signs that often indicate the onset of Alzheimer's, such as less plaque buildup. Nerves and the neurons they are made of are another factor critical for brain health, especially in advanced age. Superagers were discovered to have larger entorhinal neurons, which are found in the entorhinal cortex and involved in memory of times, places and objects. Their cholinergic nerves, which are involved in memory and help control many physical processes, are especially well preserved. There is also a greater density of von Economo neurons, which speed up information processing, in their brains. Microglia, cells which are found in nerve fibers and often behind brain inflammation and lesions in older individuals, are less prone to causing inflammation in superagers. Something that surprised the Northwestern research team was that superagers did not necessarily have many lifestyle parallels. Some took every measure to keep themselves healthy. Others had done just about everything that would seem to counter that, such as smoking, drinking, and being sedentary. Many suffered from stress and were not able to get adequate sleep. The one thing that most superagers did have in common was that they were had active social lives, making extracurricular activities a regular part of their lives. They even reported having more positive relationships with others than people around the same age who were cognitively average. Eventually, the structure and function of superager brains may be the basis for preventative treatments and gene therapies targeting Alzheimer's, other dementias, and more neurodegenerative diseases such as Parkinson's. There are some aspects of this phenomenon that have yet to surface: whether superagers are born with larger brains, or with factors that make their brains almost immune to the ravages of time that cause others to experience the effects of brain degeneration. Either way, researchers are going to remember these findings for future studies. 'In the future, deeper characterization of the superaging phenotype may lead to interventions that enhance resistance and resilience to involutional changes considered part of average (i.e., 'normal') brain aging,' the researchers said. 'This line of work is helping to revise common misperceptions about the cognitive potential of senescence and has inspired [more] investigations.' You Might Also Like The Do's and Don'ts of Using Painter's Tape The Best Portable BBQ Grills for Cooking Anywhere Can a Smart Watch Prolong Your Life? Solve the daily Crossword
Yahoo
41 minutes ago
- Yahoo
mRNA tech could help fight cancer, but cuts threaten progress, experts say
If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again. These types of vaccines use messenger RNA, or mRNA, to prompt the body to make proteins that induce an antibody response to protect against a pathogen. The science behind it is also being studied for a wide range of other uses, from fighting cancer to treating autoimmune conditions and more. Health experts have criticized the move to defund this research, pointing to the impact it will have on America's ability to develop breakthroughs against deadly or debilitating diseases. Jeff Coller, professor of RNA biology and therapeutics at Johns Hopkins University, called the cuts a "completely reckless decision from Robert F. Kennedy Jr." that was "clearly being made for political motivations and not those that are rested in our science." Former Surgeon General Dr. Jerome Adams, who served in the first Trump administration, said the technology "helps us develop vaccines and new treatments," and warned that cuts could halt progress in one of the "most promising areas of modern medicine." "People are going to die because we're cutting short funding for this technology," Adams said in a recent appearance on CBS News' "Face the Nation with Margaret Brennan." mRNA studied for pancreatic cancer, rare diseases and more Collier said one of the most exciting avenues for mRNA technology is in the treatment of deadly cancers, including pancreatic cancer, which is fatal for many patients within six months to a year. In recent years, researchers have been testing the effectiveness of using an mRNA vaccine to target the cancer. A small NIH-funded clinical trial by Sloan Kettering in 2023 used infusions of an mRNA vaccine to help boost T cells in the immune system of pancreatic cancer patients. The results, published in the journal Nature, showed improvements among about 50% of participants. "It was, in essence, the start of a cure for pancreatic cancer, where half of the patients in that study were surviving," Coller said. The early results encouraged scientists, but the small sample size called for further studies, which led to a Phase 2 trial published in Nature earlier this year. Experimental mRNA-focused treatments have also showed promise in fighting lung, colorectal and gastric cancers. For example, a study published online in the journal Gastric Cancer found a mRNA-based vaccine led to robust gastric tumor regression in mice. And earlier this year, the world was was awed by news that an infant named KJ Muldoon became the first patient to undergo personalized gene-editing treatment using a technique known as CRISPR to fix a rare and potentially fatal genetic disorder. As Coller pointed out, the CRISPR technology had to be delivered via mRNA. "This opens a floodgate for rare diseases," he said. "We're now talking about, could we use the same technology to go after all rare diseases?" Autoimmune diseases are another area of research, for treating things like multiple sclerosis, Type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and celiac disease. While all of these are still at the early research stage, Coller urged the importance of investing in this technology now for future progress. "We need to do experiments and see where we can get with the next generation of mRNA-based drugs," he said. Like with COVID-19, there has also been continued research on mRNA-based vaccines for infectious diseases like the flu, RSV, Zika virus and cytomegalovirus, known as CMV, an infection that can be harmful to babies exposed during the mother's pregnancy. "We're at a point where, if we continue to develop this technology, we'll get more personalized, bespoke medicine that we can use on patients and improve health care outcomes," Coller said. How is mRNA medicine so versatile? RNA stands for ribonucleic acid, an essential molecule in the body's cells. It is similar to DNA but has different functions. Messenger RNA, or mRNA, carries the information required for making proteins. As Coller put it: "If your DNA is a cookbook, your mRNA is an individual recipe that's telling your body what to do." To harness that power for treating disease, "All we're doing with this technology is giving it new recipes. We're taking advantage of this powerful natural system that exists in your body," he said. The versatility and potential to help such a range of illnesses is what has experts like Coller — who was not immediately impacted by the funding cuts — hoping the administration will reinstate funding for mRNA research. "We have to keep moving forward," he said. "People wanting to improve their family's lives and their children's lives is a bipartisan issue, it's truly an American issue. So we've got to keep moving." President Trump says meeting with Russia's Putin is not to broker peace deal in Ukraine Trump says he's placing D.C. police under federal control, deploying National Guard Could Tropical Storm Erin become the first Atlantic hurricane of 2025? Solve the daily Crossword
